FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743294273> ?p ?o ?g. }

• W2743294273 endingPage "39" @default.
• W2743294273 startingPage "39" @default.
• W2743294273 abstract "<h3>Importance</h3> Current information on the prevalence and sociodemographic and clinical profiles of individuals in the general population with<i>DSM-5</i>drug use disorder (DUD) is limited. Given the present societal and economic context in the United States and the new diagnostic system, up-to-date national information is needed from a single uniform data source. <h3>Objective</h3> To present nationally representative findings on the prevalence, correlates, psychiatric comorbidity, disability, and treatment of<i>DSM-5</i>DUD diagnoses overall and by severity level. <h3>Design, Setting, and Participants</h3> In-person interviews were conducted with 36 309 adults in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions–III, a cross-sectional representative survey of the United States. The household response rate was 72%; person-level response rate, 84%; and overall response rate, 60.1%. Data were collected April 2012 through June 2013 and analyzed from February through March 2015. <h3>Main Outcomes and Measures</h3> Twelve-month and lifetime DUD, based on amphetamine, cannabis, club drug, cocaine, hallucinogen, heroin, nonheroin opioid, sedative/tranquilizer, and/or solvent/inhalant use disorders. <h3>Results</h3> Prevalences of 12-month and lifetime DUD were 3.9% and 9.9%, respectively. Drug use disorder was generally greater among men, white and Native American individuals, younger and previously or never married adults, those with lower education and income, and those residing in the West. Significant associations were found between 12-month and lifetime DUD and other substance use disorders. Significant associations were also found between any 12-month DUD and major depressive disorder (odds ratio [OR], 1.3; 95% CI, 1.09-1.64), dysthymia (OR, 1.5; 95% CI, 1.09-2.02), bipolar I (OR, 1.5; 95% CI, 1.06-2.05), posttraumatic stress disorder (OR, 1.6; 95% CI, 1.27-2.10), and antisocial (OR, 1.4; 95% CI, 1.11-1.75), borderline (OR, 1.8; 95% CI, 1.41-2.24), and schizotypal (OR, 1.5; 95% CI, 1.18-1.87) personality disorders. Similar associations were found for any lifetime DUD with the exception that lifetime DUD was also associated with generalized anxiety disorder (OR, 1.3; 95% CI, 1.06-1.49), panic disorder (OR, 1.3; 95% CI, 1.06-1.59), and social phobia (OR, 1.3; 95% CI, 1.09-1.64). Twelve-month DUD was associated with significant disability, increasing with DUD severity. Among respondents with 12-month and lifetime DUD, only 13.5% and 24.6% received treatment, respectively. <h3>Conclusions and Relevance</h3> <i>DSM-5</i>DUD is a common, highly comorbid, and disabling disorder that largely goes untreated in the United States. These findings indicate the need for additional studies to understand the broad relationships in more detail; estimate present-day economic costs of DUDs; investigate hypotheses regarding etiology, chronicity, and treatment use; and provide information to policy makers about allocation of resources for service delivery and research. Findings also indicate an urgent need to destigmatize DUD and educate the public, clinicians, and policy makers about its treatment to encourage affected individuals to obtain help." @default.
• W2743294273 created "2017-08-17" @default.
• W2743294273 creator A5001511079 @default.
• W2743294273 creator A5002218939 @default.
• W2743294273 creator A5006572902 @default.
• W2743294273 creator A5014728830 @default.
• W2743294273 creator A5015015256 @default.
• W2743294273 creator A5026108455 @default.
• W2743294273 creator A5051829199 @default.
• W2743294273 creator A5054033636 @default.
• W2743294273 creator A5071925213 @default.
• W2743294273 creator A5085642649 @default.
• W2743294273 creator A5088598474 @default.
• W2743294273 date "2016-01-01" @default.
• W2743294273 modified "2023-10-18" @default.
• W2743294273 title "Epidemiology of<i>DSM-5</i>Drug Use Disorder" @default.
• W2743294273 cites W131941063 @default.
• W2743294273 cites W1502575968 @default.
• W2743294273 cites W1506603089 @default.
• W2743294273 cites W1839921965 @default.
• W2743294273 cites W1936787120 @default.
• W2743294273 cites W1984840298 @default.
• W2743294273 cites W1993427030 @default.
• W2743294273 cites W1993868596 @default.
• W2743294273 cites W1994667566 @default.
• W2743294273 cites W2004458660 @default.
• W2743294273 cites W2005172486 @default.
• W2743294273 cites W2009839039 @default.
• W2743294273 cites W2020607346 @default.
• W2743294273 cites W2022677793 @default.
• W2743294273 cites W2024560776 @default.
• W2743294273 cites W2024773432 @default.
• W2743294273 cites W2028877810 @default.
• W2743294273 cites W2031119880 @default.
• W2743294273 cites W2041002668 @default.
• W2743294273 cites W2044952163 @default.
• W2743294273 cites W2052342852 @default.
• W2743294273 cites W2060469587 @default.
• W2743294273 cites W2080673930 @default.
• W2743294273 cites W2081264030 @default.
• W2743294273 cites W2112871310 @default.
• W2743294273 cites W2114923587 @default.
• W2743294273 cites W2118826874 @default.
• W2743294273 cites W2121966275 @default.
• W2743294273 cites W2124058583 @default.
• W2743294273 cites W2126405975 @default.
• W2743294273 cites W2138560568 @default.
• W2743294273 cites W2140616116 @default.
• W2743294273 cites W2141693119 @default.
• W2743294273 cites W2146374094 @default.
• W2743294273 cites W2146878072 @default.
• W2743294273 cites W2149617260 @default.
• W2743294273 cites W2154058918 @default.
• W2743294273 cites W2159061031 @default.
• W2743294273 cites W2159160564 @default.
• W2743294273 cites W2162363996 @default.
• W2743294273 cites W2168184373 @default.
• W2743294273 cites W2169720270 @default.
• W2743294273 cites W2345309666 @default.
• W2743294273 cites W4236382531 @default.
• W2743294273 cites W4245700753 @default.
• W2743294273 cites W97547660 @default.
• W2743294273 doi "https://doi.org/10.1001/jamapsychiatry.2015.2132" @default.
• W2743294273 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5062605" @default.
• W2743294273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26580136" @default.
• W2743294273 hasPublicationYear "2016" @default.
• W2743294273 type Work @default.
• W2743294273 sameAs 2743294273 @default.
• W2743294273 citedByCount "629" @default.
• W2743294273 countsByYear W27432942732016 @default.
• W2743294273 countsByYear W27432942732017 @default.
• W2743294273 countsByYear W27432942732018 @default.
• W2743294273 countsByYear W27432942732019 @default.
• W2743294273 countsByYear W27432942732020 @default.
• W2743294273 countsByYear W27432942732021 @default.
• W2743294273 countsByYear W27432942732022 @default.
• W2743294273 countsByYear W27432942732023 @default.
• W2743294273 crossrefType "journal-article" @default.
• W2743294273 hasAuthorship W2743294273A5001511079 @default.
• W2743294273 hasAuthorship W2743294273A5002218939 @default.
• W2743294273 hasAuthorship W2743294273A5006572902 @default.
• W2743294273 hasAuthorship W2743294273A5014728830 @default.
• W2743294273 hasAuthorship W2743294273A5015015256 @default.
• W2743294273 hasAuthorship W2743294273A5026108455 @default.
• W2743294273 hasAuthorship W2743294273A5051829199 @default.
• W2743294273 hasAuthorship W2743294273A5054033636 @default.
• W2743294273 hasAuthorship W2743294273A5071925213 @default.
• W2743294273 hasAuthorship W2743294273A5085642649 @default.
• W2743294273 hasAuthorship W2743294273A5088598474 @default.
• W2743294273 hasBestOaLocation W27432942731 @default.
• W2743294273 hasConcept C107130276 @default.
• W2743294273 hasConcept C118552586 @default.
• W2743294273 hasConcept C125920245 @default.
• W2743294273 hasConcept C126322002 @default.
• W2743294273 hasConcept C144024400 @default.
• W2743294273 hasConcept C149923435 @default.
• W2743294273 hasConcept C151730666 @default.
• W2743294273 hasConcept C185592680 @default.

• next